NFKB1 and pachyonychia congenita: Activation of ERK, NF-kB and JAK/STAT pathways leads to PD-L1 expression, regardless of the tumor sample (primary vs. metastatic) and of the androgen responsiveness/resistance of the analyzed PC-cell lines.